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Book Reviews
Molecular Genetics of Pediatric Solid Tumours
Edited by G.P. Tonini, R. Sansone & C.J. Thiele, Philadel-
phia: Harwood, 1992, 382pp. £25.00
This is a timely book. Ten years ago, molecular biology was
purely a research tool holding out the faint hope of improv-
ing our understanding of malignancy. Now it is part of the
day to day management ofpatients with cancer and promises
to have an increasing role in the future. Characteristic
chromosome translocations can be useful in diagnosis e.g.;
t(ll;22) translocation in Ewings sarcoma, and can be identi-
fied by high definition cytogenetics or fluorescent in situ
hybridisation (FISH). Cytogenetic changes or amplification
of oncogenes have prognostic value and much work is at
present directed to molecular therapeutics; for example the
use of antisense oligonucleotides to block 'over active'
oncogenes. Many other books have been published on molec-
ular genetics. Most explain the concepts of oncogenes and
tumour suppressors and introduce the general reader to basic
molecular technology such as Southern blotting and the
polymerase chain reaction. This book differs from the above
in that it concentrates on paediatric solid tumours and aims
to introduce the reader to a broader spectrum of molecular
technology.
It consists of 16 chapters and is divided into two sections,
the first introducing recent perspectives in molecular genetics
and the second focusing on the application of these principles
to specific pathologies. The distinction is not, however, rigid
and some of the best chapters interweave both elements. The
susceptibility to cancer is discussed in an early chapter which
gives a brief overview of the syndromes associated with
increased risks of malignancy. Chapters on chromosomal
abnormalities and fragile sites follows. Oncogenes, tumour
suppressors and their role in the cell cycle are all dealt with
in some depth and there are particularly good chapters on
oncoproteins and gene amplification. All standard stuff, but
where else would one read about transgenic mice, flow
cytometry and murine modelling of neuroblastoma? In the
section on specific pathologies the authors have, quite rightly,
concentrated on those paediatric malignancies where molec-
ular genetics have made an impact rather than listing unsub-
stantiated findings ofdubious significance for a wide range of
childhood tumours. This does, however, limit the number of
different malignancies that can be discussed and results in a
fair degree of repetition (there are five chapters on different
aspects of neuroblastoma for example). There are excellent
chapters on retinoblastoma, rhabdomyosarcoma, the Wilms'
tumour candidate gene and brain tumours.
However, what the book has in breadth it sometimes lacks
in consistency. The standard of knowledge expected of the
reader varies significantly from chapter to chapter with some
presenting hugely detailed molecular findings rendering them
indigestible for the non-specialist. Similarly, although most of
the technique based chapters concentrate on concepts, some
give excess detail including step by step experimental
methodology. The truly international authorship ensures a
stimulating diversity of approach but does make the style of
writing very variable and sometimes difficult to follow.
These criticisms aside I enjoyed the book and felt it
fulfilled the role it set itself. The book is dedicated to Dr
Raffaele Sansone, one of the three editors, who died tragic-
ally before it was published. I think he would have been
proud of the finished result.
A.J. Michalski
Breast Cancer Treatment. A Comprehensive Guide to Manage-
ment
B. Fowble, R.L. Goodman, J.H. Glick & E.F. Rosato, St.
Louis, Missouri: Mosby-Year Book Inc., 1991, 647 pp.
This excellent book is devoted entirely to the treatment of
established breast cancer; it is not concerned with epi-
demiology, prevention, screening or benign breast disease.
Despite the parochial authorship (31 of the 34 authors are
from Philadelphia) the coverage of the subject is comprehen-
sive and the book deserves a wide readership.
The locoregional treatment of early invasive breast cancer
including breast conserving surgery is covered exhaustively
and the extensive literature is critically reviewed in a detailed
painstaking way. Witness the confusing data on the relevance
of locoregional treatment to survival. Often no clear answers
are provided, but this will be familiar to those working in
this controversial field of oncology. This does not in any way
detract from the excellence of the book as this approach is
far preferable to the repetition of potentially misleading
dogma. The role of mammography in evaluating patients
before treatment is dealt with in a lucid and authoritative
fashion, well-illustrated by good quality photographs, a
feature also of the chapter on the evaluation of patients
treated by breast-conserving treatment and radiotherapy.
Prognostic factors, both pathological and new markers, and
adjuvant systemic therapy receive good up-to-date accounts.
British readers will generally find the recommendations for
treatment to be in tune with practice here, meta-analyses
having done much in recent years to achieve a trans-Atlantic
convergence of views. Good chapters deal with reconstructive
surgery, in situ disease, locally advanced breast cancer,
metastatic disease and its complications, and psychological
aspects. There are useful sections on special circumstances
such as Paget's disease, breast cancer in pregnancy and in
men and bilateral disease. Breast cancer is a major source of
malpractice claims in the USA where it has become the most
expensive disease for professional insurers and so the editors
have given the last word to three lawyers in a chapter on
medico-legal aspects. On searching the book for significant
omissions, none were found.
There is really very little with which to take exception and
to highlight any such minor points here would give them
inappropriate prominence in what is intended to be an ex-
tremely favourable review. A particular merit of the book is
its value as a reference work to facilitate access to the vast
literature on the treatment of breast cancer. In this context,
the quality of tables summarising salient points in key
references is excellent. This admirable text is highly recom-
mended to all involved in treating breast cancer.
R.D. Rubens
Mutant Oncogenes. Targets for Therapy
Edited by N. Lemoine & A. Epenetos, London: Chapman &
Hall Medical, 1992 209 pp. £55.00.
This book is edited by Nicholas Lemoine and Agememnon
Epenetos and is a collection of papers presented at a meeting
in London in September 1991. The book is divided into three
parts. I: Growth factors and their receptors as targets for
therapy, II: Intracellular oncogene products as targets for
therapy, and III: Tumour-suppressor genes and immortalis-